BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 25061216)

  • 1. Incidence and severity of primary graft dysfunction after lung transplantation using rejected grafts reconditioned with ex vivo lung perfusion.
    Boffini M; Ricci D; Bonato R; Fanelli V; Attisani M; Ribezzo M; Solidoro P; Del Sorbo L; Ranieri VM; Rinaldi M
    Eur J Cardiothorac Surg; 2014 Nov; 46(5):789-93. PubMed ID: 25061216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early results in transplantation of initially rejected donor lungs after ex vivo lung perfusion: a case-control study.
    Wallinder A; Ricksten SE; Silverborn M; Hansson C; Riise GC; Liden H; Jeppsson A; Dellgren G
    Eur J Cardiothorac Surg; 2014 Jan; 45(1):40-4; discussion 44-5. PubMed ID: 23666375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First experience with ex vivo lung perfusion for initially discarded donor lungs in the Netherlands: a single-centre study.
    Zhang ZL; van Suylen V; van Zanden JE; Van De Wauwer C; Verschuuren EAM; van der Bij W; Erasmus ME
    Eur J Cardiothorac Surg; 2019 May; 55(5):920-926. PubMed ID: 30496383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung transplantation from initially rejected donors after ex vivo lung reconditioning: the French experience.
    Sage E; Mussot S; Trebbia G; Puyo P; Stern M; Dartevelle P; Chapelier A; Fischler M;
    Eur J Cardiothorac Surg; 2014 Nov; 46(5):794-9. PubMed ID: 25061219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK.
    Fisher A; Andreasson A; Chrysos A; Lally J; Mamasoula C; Exley C; Wilkinson J; Qian J; Watson G; Lewington O; Chadwick T; McColl E; Pearce M; Mann K; McMeekin N; Vale L; Tsui S; Yonan N; Simon A; Marczin N; Mascaro J; Dark J
    Health Technol Assess; 2016 Nov; 20(85):1-276. PubMed ID: 27897967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-free DNA in human ex vivo lung perfusate as a potential biomarker to predict the risk of primary graft dysfunction in lung transplantation.
    Kanou T; Nakahira K; Choi AM; Yeung JC; Cypel M; Liu M; Keshavjee S
    J Thorac Cardiovasc Surg; 2021 Aug; 162(2):490-499.e2. PubMed ID: 32928548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of marginal donors for lung transplantation after ex vivo lung perfusion: A systematic review and meta-analysis.
    Tian D; Wang Y; Shiiya H; Sun CB; Uemura Y; Sato M; Nakajima J
    J Thorac Cardiovasc Surg; 2020 Feb; 159(2):720-730.e6. PubMed ID: 31548078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it possible to further improve the function of pulmonary grafts by extending the duration of lung reconditioning using ex vivo lung perfusion?
    Pierre L; Lindstedt S; Hlebowicz J; Ingemansson R
    Perfusion; 2013 Jul; 28(4):322-7. PubMed ID: 23436723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended post-ex vivo lung perfusion cold preservation predicts primary graft dysfunction and mortality: Results from a multicentric study.
    Leiva-Juárez MM; Urso A; Arango Tomás E; Lederer DJ; Sanchez P; Griffith B; Davis RD; Daneshmand M; Hartwig M; Cantu E; Weyant MJ; Bermudez C; D'Cunha J; Machuca T; Wozniak T; Lynch W; Nemeh H; Mulligan M; Song T; Jessen M; Camp PC; Caldeira C; Whitson B; Kreisel D; Ramzy D; D'Ovidio F
    J Heart Lung Transplant; 2020 Sep; 39(9):954-961. PubMed ID: 32475748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic and functional evaluation of lungs reconditioned by ex vivo lung perfusion.
    Medeiros IL; Pêgo-Fernandes PM; Mariani AW; Fernandes FG; do Vale Unterpertinger F; Canzian M; Jatene FB
    J Heart Lung Transplant; 2012 Mar; 31(3):305-9. PubMed ID: 22133788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo lung perfusion increases the pool of lung grafts: analysis of its potential and real impact on a lung transplant program.
    Boffini M; Ricci D; Barbero C; Bonato R; Ribezzo M; Mancuso E; Attisani M; Simonato E; Magistroni P; Mansouri M; Solidoro P; Baldi S; Pasero D; Amoroso A; Rinaldi M
    Transplant Proc; 2013 Sep; 45(7):2624-6. PubMed ID: 24034008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation after ex vivo lung perfusion: A midterm follow-up.
    Wallinder A; Riise GC; Ricksten SE; Silverborn M; Dellgren G
    J Heart Lung Transplant; 2016 Nov; 35(11):1303-1310. PubMed ID: 27381674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of initially rejected donor lungs after ex vivo lung perfusion.
    Wallinder A; Ricksten SE; Hansson C; Riise GC; Silverborn M; Liden H; Olausson M; Dellgren G
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1222-8. PubMed ID: 22995721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcome of Patients Transplanted with Marginal Donor Lungs via Ex Vivo Lung Perfusion Compared to Standard Lung Transplantation.
    Fildes JE; Archer LD; Blaikley J; Ball AL; Stone JP; Sjöberg T; Steen S; Yonan N
    Transplantation; 2015 May; 99(5):1078-83. PubMed ID: 25757211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with early graft dysfunction in cystic fibrosis patients receiving primary bilateral lung transplantation.
    Felten ML; Sinaceur M; Treilhaud M; Roze H; Mornex JF; Pottecher J; Journois D; Fischler M
    Eur J Cardiothorac Surg; 2012 Mar; 41(3):686-90. PubMed ID: 22345188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with the first 50 ex vivo lung perfusions in clinical transplantation.
    Cypel M; Yeung JC; Machuca T; Chen M; Singer LG; Yasufuku K; de Perrot M; Pierre A; Waddell TK; Keshavjee S
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1200-6. PubMed ID: 22944089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten year follow-up of lung transplantations using initially rejected donor lungs after reconditioning using ex vivo lung perfusion.
    Ghaidan H; Fakhro M; Andreasson J; Pierre L; Ingemansson R; Lindstedt S
    J Cardiothorac Surg; 2019 Jul; 14(1):125. PubMed ID: 31262311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of lung edema during ex-vivo lung perfusion by single transpulmonary thermodilution: A preliminary study in humans.
    Trebbia G; Sage E; Le Guen M; Roux A; Soummer A; Puyo P; Parquin F; Stern M; Pham T; Sakka SG; Cerf C;
    J Heart Lung Transplant; 2019 Jan; 38(1):83-91. PubMed ID: 30391201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein expression profiling predicts graft performance in clinical ex vivo lung perfusion.
    Machuca TN; Cypel M; Yeung JC; Bonato R; Zamel R; Chen M; Azad S; Hsin MK; Saito T; Guan Z; Waddell TK; Liu M; Keshavjee S
    Ann Surg; 2015 Mar; 261(3):591-7. PubMed ID: 25371129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Profile of Ex Vivo Lung Perfusate Yields Biomarkers for Lung Transplant Outcomes.
    Hsin MK; Zamel R; Cypel M; Wishart D; Han B; Keshavjee S; Liu M
    Ann Surg; 2018 Jan; 267(1):196-197. PubMed ID: 29240608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.